POP-OUT | CLOSE

An Information Portal to 107754 Biological Macromolecular Structures

Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 11mer epitope
Sequence Clustering and Redundancy Reduction Results
1TJH
Cluster # 1 Members. Sequence cutoff: 50% Cluster size: 3218 sequences | showing only first 1000 cluster members
Rank   PDB id Entity id Chains Description Details Taxonomy EC Number
Select for download / view details OR: Select two chains for comparison
  Download      Details  
1 4NZU 1 L 13PL heavy chain Fab 9606  
2 4NZU 2 H 13PL light chain Fab 9606  
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090  
5 1MEX 1 L Fab 29G12 light chain 10090  
6 1MEX 2 H Fab 29G12 heavy chain 10090  
7 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090  
8 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090  
9 4BUH 1 A, B CLONE M0418 SCFV 9606  
10 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606  
11 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606  
12 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090  
13 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090  
14 2XZC 1 H FAB A.17 HEAVY CHAIN 9606  
15 2XZC 2 L FAB A.17 LIGHT CHAIN 9606  
16 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090  
17 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090  
18 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090  
19 1RUP 2 H immunoglobulin igg2a, light chain fab 10090  
20 1RUK 1 L immunoglobulin igg2a, light chain fab 10090  
21 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090  
22 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606  
23 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606  
24 2VXV 1 H HUMAN IGG ABT-325 9606  
25 2VXV 2 L HUMAN IGG ABT-325 9606  
26 4GXV 1 H, I Antibody 1F1, heavy chain 9606  
27 4GXV 2 L, M Antibody 1F1, light chain 9606  
28 2VXT 1 H MURINE IGG 125-2H 10090  
29 2VXT 3 L MURINE IGG 125-2H 10090  
30 1RUM 1 L immunoglobulin igg2a, light chain fab 10090  
31 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090  
32 2XZA 1 H FAB A.17 HEAVY CHAIN 9606  
33 2XZA 2 L FAB A.17 LIGHT CHAIN 9606  
34 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
35 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
36 4HPY 1 H CH59 Fab heavy chain 9606  
37 4HPY 2 L CH59 Fab light chain 9606  
38 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090  
39 3T65 2 A S25-2 FAB (IGG1K) light chain 10090  
40 4JG1 1 L Fab light chain 9606  
41 4JG1 2 H Fab heavy chain 9606  
42 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606  
43 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606  
44 4O5L 1 L Fab F045-092 light chain Fab F045-092 light chain 9606  
45 4O5L 2 H Fab F045-092 heavy chain Fab F045-092 heavy chain 9606  
46 3IFL 1 L 12A11 FAB antibody light chain 10090  
47 3IFL 2 H 12A11 FAB antibody heavy chain 10090  
48 3PP4 1 H GA101 Fab heavy chain 10090  
49 3PP4 2 L GA101 Fab light chain 10090  
50 3KDM 1 A, L Immunoglobulin light chain 9606  
51 3KDM 2 B, H Immunoglobulin heavy chain 9606  
52 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
53 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
54 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
55 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
56 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090  
57 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090  
58 4PTU 1 A Antibody pn132p2C05, light chain 9606  
59 4PTU 2 B Antibody pn132p2C05, heavy chain 9606  
60 4HS6 2 A, L MRCT10.v362 Fab light chain 9606  
61 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606  
62 3IFN 1 H 12A11 FAB antibody heavy chain 10090  
63 3IFN 2 L 12A11 FAB antibody light chain 10090  
64 4TOY 1 H 35O22 Fab Heavy chain 9606  
65 4TOY 2 L 35O22 Fab Light chain 9606  
66 3NPS 2 B S4 FAB HEAVY CHAIN 9606  
67 3NPS 3 C S4 FAB LIGHT CHAIN 9606  
68 1RUR 1 L immunoglobulin 13G5, light chain fab 10090  
69 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090  
70 4M5Y 1 H, I Fab 5J8 heavy chain 9606  
71 4M5Y 2 L, M Fab 5J8 light chain 9606  
72 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090  
73 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090  
74 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090  
75 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090  
76 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606  
77 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606  
78 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606  
79 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606  
80 3NTC 1 L Fab light chain 10090  
81 3NTC 2 H Fab heavy chain 10090  
82 4NWU 1 H APE1551 Ab Fab heavy chain 9606  
83 4NWU 2 L APE1551 Ab Fab light chain 9606  
84 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
85 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
86 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090  
87 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090  
88 4NZR 1 H PGT135 heavy chain Fab 9606  
89 4NZR 2 L PGT135 light chain Fab 9606  
90 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986  
91 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986  
92 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090  
93 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090  
94 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090  
95 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
96 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
97 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606  
98 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606  
99 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
100 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090  
101 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090  
102 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090  
103 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
104 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
105 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606  
106 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606  
107 3QQ9 1 C, L 101F LIGHT CHAIN 10090  
108 3QQ9 2 D, H 101F HEAVY CHAIN 10090  
109 3OZ9 1 L Fab NC-1 kappa light chain 10090  
110 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090  
111 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606  
112 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606  
113 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606  
114 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606  
115 3G5Y 1 A 175 light chain 10090  
116 3G5Y 2 B 175 heavy chain 10090  
117 4N8C 1 H, I Heavy chain of monoclonal antibody 10090  
118 4N8C 2 L, M Light chain of monoclonal antibody 10090  
119 4HGW 1 A Antibody Fab fragment, light chain 10090  
120 4HGW 2 B Antibody Fab fragment, heavy chain 10090  
121 1NLB 1 L antibody 19D9D6 light chain 10090  
122 1NLB 2 H antibody 19D9D6 heavy chain 10090  
123 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
124 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090  
125 3VFG 1 L 3F8 Light Chain 10090  
126 3VFG 2 H 3F8 Heavy Chain 10090  
127 3QRG 1 L Fab light chain 9606  
128 3QRG 2 H Fab heavy chain Fd fragment 9606  
129 4LLY 2 B, D light chain Clambda 9606  
130 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090  
131 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090  
132 4K23 1 H anti-uPAR antibody, heavy chain 10090  
133 4K23 2 L anti-uPAR antibody, light chain 10090  
134 3NCJ 1 L Fab15 Mut8 light chain 9606  
135 3NCJ 2 H Fab15 Mut8 heavy chain 9606  
136 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
137 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
138 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090  
139 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090  
140 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090  
141 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090  
142 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
143 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
144 4M61 1 A, C Fab A52 light chain 10090  
145 4M61 2 B, D Fab A52 heavy chain 10090  
146 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
147 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
148 1UM5 1 L Antibody 21H3 L chain 10090  
149 1UM5 2 H Antibody 21H3 H chain 10090  
150 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606  
151 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606  
152 4NWT 1 L APE1531 Ab Fab light chain 9606  
153 4NWT 2 H APE1531 Ab Fab heavy chain 9606  
154 3WHX 1 A mAb Fab H fragment 10090  
155 3WHX 2 B mAb Fab L fragment 10090  
156 3NA9 1 L Fab15 light chain 9606  
157 3NA9 2 H Fab15 heavy chain 9606  
158 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
159 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
160 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
161 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090  
162 4LRI 1 A, B MSL-109 Light Chain 9606  
163 4LRI 2 C, P MSL-109 Heavy Chain 9606  
164 4JN2 1 A, L anti dabigatran Fab 10090  
165 4JN2 2 B, H anti dabigatran Fab 10090  
166 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090  
167 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090  
168 4JFZ 1 L Fab light chain 9606  
169 4JFZ 2 H Fab heavy chain 9606  
170 3WIF 1 A mAb Fab H fragment 10090  
171 3WIF 2 B mAb Fab L fragment 10090  
172 3MBX 1 L X836 LIGHT CHAIN 10090  
173 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090  
174 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606  
175 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606  
176 4HHA 1 A Fab KE5 Fab fragment KE5 9606  
177 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606  
178 4RGO 2 H 14G8 heavy chain Fab 10090  
179 4RGO 3 L 14G8 light chain Fab 10090  
180 3NAA 1 L Fab15 Mut5 light chain 9606  
181 3NAA 2 H Fab15 Mut5 heavy chain 9606  
182 1Q0X 1 L Fab 9B1, light chain 10090  
183 1Q0X 2 H Fab 9B1, heavy chain 10090  
184 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090  
185 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
186 4WUK 1 H CH65 heavy chain 9606  
187 4WUK 2 L CH65 light chain 9606  
188 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606  
189 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606  
190 4HPO 1 H CH58 Fab heavy chain 9606  
191 4HPO 2 L CH58 Fab light chain 9606  
192 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606  
193 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606  
194 4PUB 1 H DX-2930 HEAVY CHAIN 9606  
195 4PUB 2 L DX-2930 LIGHT CHAIN 9606  
196 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090  
197 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090  
198 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090  
199 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
200 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
201 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
202 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090  
203 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
204 3UYR 1 H antibody Fab heavy chain 10090  
205 3UYR 2 L antibody Fab light chain 10090  
206 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090  
207 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090  
208 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
209 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
210 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606  
211 3OAZ 2 K, L Fab 2G12, light chain 9606  
212 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090  
213 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
214 1ZAN 1 L Fab AD11 Light Chain 10116  
215 1ZAN 2 H Fab AD11 Heavy Chain 10116  
216 4N0Y 1 H IGH526 Heavy Chain 9606  
217 4N0Y 2 L IGH526 Light Chain 9606  
218 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
219 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
220 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090  
221 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090  
222 1RZF 1 L Fab E51 light chain 9606  
223 1RZF 2 H Fab E51 heavy chain 9606  
224 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544  
225 4KTE 2 L GE148 Light Chain Fab 9544  
226 4JG0 1 L Fab light chain 9606  
227 4JG0 2 H Fab heavy chain 9606  
228 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606  
229 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606  
230 3EO0 1 A, C GC-1008 Fab Light Chain 10090  
231 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090  
232 4FQI 3 H antibody CR9114 heavy chain Fab 9606  
233 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606  
234 4JHA 1 H D25 antigen-binding fragment heavy chain 9606  
235 4JHA 2 L D25 light chain 9606  
236 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
237 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
238 4PTT 1 A Antibody pn132p2C05, light chain 9606  
239 4PTT 2 B Antibody pn132p2C05, heavy chain 9606  
240 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606  
241 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606  
242 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090  
243 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090  
244 4DGV 1 H HCV1 Heavy Chain Fab 9606  
245 4DGV 2 L HCV1 Light Chain 9606  
246 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
247 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
248 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090  
249 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090  
250 1YNL 1 L Ig gamma light chain 10090  
251 1YNL 2 H Ig gamma heavy chain 10090  
252 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090  
253 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
254 3UMT 1 A scFv heavy chain and light chain 10090  
255 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090  
256 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090  
257 4NUJ 1 A PGT152 light chain 9606  
258 4NUJ 2 B PGT152 heavy chain 9606  
259 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090  
260 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090  
261 1RUA 1 L immunoglobulin igg2a, light chain fab 10090  
262 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090  
263 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606  
264 3U2S 2 B, L PG9 light chain 9606  
265 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090  
266 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090  
267 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090  
268 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
269 4NUG 1 L PGT151 light chain 9606  
270 4NUG 2 H PGT151 heavy chain 9606  
271 3IU4 1 H chP3 Fab heavy chain 10090  
272 3IU4 2 L chP3 Fab light chain 10090  
273 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
274 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
275 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606  
276 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606  
277 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090  
278 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090  
279 1P7K 1 A, L antibody light chain FAB 10090  
280 1P7K 2 B, H antibody heavy chain FAB 10090  
281 3RVV 2 C 4C1 - light chain 10090  
282 3RVV 3 D 4C1 - heavy chain 10090  
283 3P0Y 2 H Fab DL11 heavy chain 9606  
284 3P0Y 3 L Fab DL11 light chain 9606  
285 4NPY 1 A, L germline PGT121 light chain Fab 9606  
286 4NPY 2 B, H germline PGT121 heavy chain Fab 9606  
287 2YPV 2 H FAB 12C1 10090  
288 2YPV 3 L FAB 12C1 10090  
289 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606  
290 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606  
291 4JY5 1 L PGT122 light chain Fab 9606  
292 4JY5 2 H PGT122 heavy chain Fab 9606  
293 3NAC 1 L Fab15 Mut7 light chain 9606  
294 3NAC 2 H Fab15 Mut7 heavy chain 9606  
295 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
296 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
297 1Q72 1 L Fab M82G2, Light chain 10090  
298 1Q72 2 H Fab M82G2, Heavy chain 10090  
299 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606  
300 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606  
301 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090  
302 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090  
303 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090  
304 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
305 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
306 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
307 4DGY 1 H HCV1 Heavy Chain Fab 9606  
308 4DGY 2 L HCV1 Light Chain 9606  
309 3T77 1 A S25-2 FAB (IGG1K) light chain 10090  
310 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090  
311 3MXW 2 L 5E1 light chain 9606  
312 3MXW 3 H 5E1 heavy chain 9606  
313 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630  
314 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630  
315 3EO9 1 L Efalizumab Fab fragment, light chain 9606  
316 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606  
317 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090  
318 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090  
319 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090  
320 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090  
321 3C6S 1 A, C, E, G Fab F22-4 light chain 10090  
322 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090  
323 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090  
324 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090  
325 4JM4 1 H PGT 135 Heavy Chain Fab 9606  
326 4JM4 2 L PGT 135 Light Chain Fab 9606  
327 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
328 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
329 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090  
330 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090  
331 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
332 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090  
333 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090  
334 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090  
335 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606  
336 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606  
337 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606  
338 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606  
339 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606  
340 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606  
341 2FX7 1 L Fab 4E10 Light Chain 9606  
342 2FX7 2 H Fab 4E10 Heavy Chain 9606  
343 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606  
344 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606  
345 3WFH 1 A mAb Fab H fragment 10090  
346 3WFH 2 B mAb Fab L fragment 10090  
347 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913  
348 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913  
349 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606  
350 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606  
351 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
352 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090  
353 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
354 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
355 3RVW 2 C 4C1 - light chain 10090  
356 3RVW 3 D 4C1 - heavy chain 10090  
357 3D85 1 A FAB of antibody 7G10, light chain light chain 9606  
358 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606  
359 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090  
360 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090  
361 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
362 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
363 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090  
364 4JN1 2 L anti-dabigatran Fab1, light chain 10090  
365 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090  
366 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090  
367 4G5Z 1 H canakinumab antibody fragment heavy chain 9606  
368 4G5Z 2 L canakinumab antibody fragment light chain 9606  
369 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606  
370 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606  
371 2OK0 2 L Fab ED10 light chain 10090  
372 2OK0 3 H Fab ED10 heavy chain 10090  
373 3SOB 1 L antibody light chain 9606  
374 3SOB 3 H antibody heavy chain 9606  
375 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090  
376 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090  
377 2IH3 1 A FAB Heavy Chain 10090  
378 2IH3 2 B FAB Light Chain 10090  
379 4KQ3 1 L CNTO3186 light chain Fab 9606  
380 4KQ3 2 H CNTO3186 heavy chain Fab 9606  
381 4JFX 1 A, L Fab light chain 9606  
382 4JFX 2 B, H Fab heavy chain 9606  
383 3SGE 1 I, L Light Chain 10090  
384 3SGE 2 H, J Heavy Chain 10090  
385 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090  
386 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090  
387 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
388 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
389 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606  
390 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606  
391 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090  
392 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090  
393 1JGU 1 L Antibody Light Chain 10090  
394 1JGU 2 H Antibody Heavy Chain 10090  
395 4I77 1 H Lebrikizumab heavy chain Fab 9606  
396 4I77 2 L Lebrikizumab light chain Fab 9606  
397 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606  
398 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606  
399 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986  
400 4O4Y 2 H 2095-2 heavy chain 9986  
401 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
402 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090  
403 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
404 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090  
405 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031  
406 4GLR 3 I, K anti-ptau light chain light chain 9031  
407 4HJG 1 A Trastuzumab light chain 9606  
408 4HJG 2 B Trastuzumab heavy chain 9606  
409 4M43 1 L Fragment antigen-binding 523-11 light chain 10090  
410 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090  
411 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
412 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
413 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
414 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
415 3FN0 1 L Fab Z13e1 light chain 9606  
416 3FN0 2 H Fab Z13e1 heavy chain 9606  
417 4OSU 1 H SM5-1 Fab Heavy Chain 9606  
418 4OSU 2 L SM5-1 Fab Light Chain 9606  
419 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090  
420 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090  
421 1T2Q 1 L Fab NNA7 Heavy Chain 10090  
422 1T2Q 2 H Fab NNA7 Light Chain 10090  
423 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090  
424 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090  
425 4MAU 1 L C2244 light chain SEE REMARK 999 10090  
426 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090  
427 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090  
428 3LEX 2 B, L 11f10 Antibody Light Chain 10090  
429 1OP3 1 K, L FAB 2G12, light chain light chain 9606  
430 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606  
431 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090  
432 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
433 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606  
434 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606  
435 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606  
436 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606  
437 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
438 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090  
439 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090  
440 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090  
441 3S96 1 A, C 3B5H10 FAB heavy chain 10090  
442 3S96 2 B, D 3B5H10 FAB light chain 10090  
443 4LKX 1 A Fab fragment heavy chain 9606  
444 4LKX 2 B Fab fragment light chain 9606  
445 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090  
446 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
447 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606  
448 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606  
449 4FQ2 1 H Fab heavy chain 9606  
450 4FQ2 2 L Fab light chain 9606  
451 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090  
452 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090  
453 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090  
454 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090  
455 2A77 1 L Immunoglobulin Light Chain 10090  
456 2A77 2 H Immunoglobulin Heavy Chain 10090  
457 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606  
458 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606  
459 3GO1 1 L Fab 268-D, light chain 9606  
460 3GO1 2 H Fab 268-D, heavy chain 9606  
461 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090  
462 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090  
463 3QWO 1 B, L motavizumab light chain 10090  
464 3QWO 2 A, H motavizumab heavy chain 10090  
465 3CVI 1 H 25-D1.16 Heavy chain 10090  
466 3CVI 2 L 25-D1.16 Light chain 10090  
467 1PZ5 1 A Light chain of Fab (SYA/J6) 10090  
468 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090  
469 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116  
470 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116  
471 4IOI 1 A Trastuzumab light chain 9606  
472 4IOI 2 B Trastuzumab heavy chain 9606  
473 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090  
474 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090  
475 4OKV 1 A, C heavy chain of 8H7 mAb 10090  
476 4OKV 2 B, D light chain of 8H7 mAb 10090  
477 1JGV 1 L Antibody Light Chain 10090  
478 1JGV 2 H Antibody Heavy Chain 10090  
479 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606  
480 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606  
481 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090  
482 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090  
483 2ADF 2 H 82D6A3 IgG FAB 10090  
484 2ADF 3 L 82D6A3 IgG FAB 10090  
485 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090  
486 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090  
487 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544  
488 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544  
489 1UM4 1 L Antibody 21H3 L chain 10090  
490 1UM4 2 H Antibody 21H3 H chain 10090  
491 4RBP 1 K, L Fab 2G12 light chain 9606  
492 4RBP 2 H, M Fab 2G12 heavy chain 9606  
493 3I75 1 A Antibody heavy chain 10090  
494 3I75 2 B Antibody light chain 10090  
495 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606  
496 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606  
497 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606  
498 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606  
499 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
500 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090  
501 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090  
502 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090  
503 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090  
504 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090  
505 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
506 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
507 3OAY 1 K, L Fab 2G12, light chain 9606  
508 3OAY 2 H, M Fab 2G12, heavy chain 9606  
509 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090  
510 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090  
511 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
512 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
513 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
514 1YEJ 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
515 4GMT 1 L, M Fab S139/1 light chain 10090  
516 4GMT 2 H, I Fab S139/1 heavy chain 10090  
517 3ZKM 2 C, H FAB HEAVY CHAIN 9606  
518 3ZKM 3 D, L FAB LIGHT CHAIN 10090  
519 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090  
520 1FNS 2 H IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, HEAVY CHAIN 10090  
521 3HNS 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
522 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090  
523 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
524 1KEL 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
525 4DCQ 1 A 3B5H10 FAB Light Chain 10090  
526 4DCQ 2 B 3B5H10 FAB Heavy Chain 10090  
527 3TCL 1 A, H CH04 Heavy Chain Fab 9606  
528 3TCL 2 B, L CH04 Light Chain Fab 9606  
529 3QOT 1 L B3 (IGKV4-1) light chain 9606  
530 3QOT 2 H 1-69 (IGHV1-69) heavy chain FD 9606  
531 4OJF 1 H Humanised 3D6 Fab Heavy Chain 10090  
532 4OJF 2 L Humanised 3D6 Fab Light Chain 10090  
533 1N0X 1 L, M IMMUNOGLOBULIN LIGHT CHAIN 9606  
534 1N0X 2 H, K IMMUNOGLOBULIN HEAVY CHAIN 9606  
535 2FAT 1 L FAB ATN-615, light chain 10090  
536 2FAT 2 H FAB ATN-615, heavy chain 10090  
537 1RUL 1 L immunoglobulin igg2a, light chain fab 10090  
538 1RUL 2 H immunoglobulin igg2a, heavy chain fab 10090  
539 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
540 1T3F 2 B Huzaf antibody heavy chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
541 4H88 2 H POM1 FAB CHAIN H 10090  
542 4H88 3 L POM1 FAB CHAIN L 10090  
543 4X7S 1 H Epididymis luminal protein 214 residues 20-241 9606  
544 4X7S 2 L Ig kappa chain C region residues 23-236 9606  
545 1UM6 1 L antibody 21h3, L chain 10090  
546 1UM6 2 H antibody 21h3, H chain 10090  
547 3H0T 1 A Fab fragment, Light chain 9606  
548 3H0T 2 B Fab fragment, Heavy chain 9606  
549 2AK1 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
550 2AK1 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
551 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
552 1S3K 2 H HU3S193 Fab fragment, heavy chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
553 3HNV 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
554 3HNV 2 L CS-35 Fab Light Chain Light Chain 10090  
555 3LEY 1 H 6a7 Antibody Heavy Chain 10090  
556 3LEY 2 L 6a7 Antibody Light Chain 10090  
557 1YEI 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING DOMAIN 10090  
558 1YEI 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING DOMAIN 10090  
559 3QPQ 1 C, E, I, L C1068 light chain 10090  
560 3QPQ 2 D, F, H, J C1068 heavy chain 10090  
561 3GJF 4 K, L Antibody light chain 9606  
562 3GJF 5 H, M Antibody heavy chain 9606  
563 3UJJ 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 4025 9606  
564 3UJJ 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 4025 9606  
565 2HFF 1 A, L CB2 Fab, light chain 9606  
566 2HFF 2 B, H CB2 Fab, heavy chain 9606  
567 4M7K 1 L 10H10 light chain SEE REMARK 999 10090  
568 4M7K 2 H 10H10 heavy chain FD, SEE REMARK 999 10090  
569 1NDG 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-8 light chain 10090  
570 1NDG 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-8 10090  
571 3OKD 1 A S25-39 Fab (IgG1k) light chain 10090  
572 3OKD 2 B S25-39 Fab (IgG1k) heavy chain 10090  
573 2IPT 1 L IgG2a Fab fragment Heavy Chain 10090  
574 2IPT 2 H IgG2a Fab fragment Light Chain Kappa 10090  
575 1SBS 1 H MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
576 1SBS 2 L MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
577 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
578 1VGE 2 H TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
579 4MA3 1 A, L C2095 light chain SEE REMARK 999 9986  
580 4MA3 2 B, H C2095 heavy chain FD, SEE REMARK 999 9986  
581 2FBJ 1 L IGA-KAPPA J539 FAB (LIGHT CHAIN) 10090  
582 2FBJ 2 H IGA-KAPPA J539 FAB (HEAVY CHAIN) 10090  
583 1RUQ 1 L immunoglobulin 13G5 light chain fab 10090  
584 1RUQ 2 H immunoglobulin 13G5 heavy chain fab 10090  
585 2HKF 1 L Immunoglobulin Light chain Fab fragment 10090  
586 2HKF 2 H Immunoglobulin Heavy chain Fab fragment 10090  
587 4M6N 1 L CNTO1959 light chain 9606  
588 4M6N 2 H CNTO1959 heavy chain FD 9606  
589 1YEC 1 L IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
590 1YEC 2 H IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
591 3UYP 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090  
592 6FAB 1 L IGG1-KAPPA 36-71 FAB (LIGHT CHAIN) 10090  
593 6FAB 2 H IGG1-KAPPA 36-71 FAB (HEAVY CHAIN) 10090  
594 3L5X 1 L H2L6 LIGHT CHAIN 9606  
595 3L5X 2 H H2L6 HEAVY CHAIN 9606  
596 2YMX 1 H FAB ANTIBODY HEAVY CHAIN VARIABLE DOMAIN 10090  
597 2YMX 2 L FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090  
598 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
599 2NXY 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
600 2R8S 2 L Fab light chain 10090  
601 2R8S 3 H Fab heavy chain 10090  
602 4HKZ 1 A Trastuzumab light chain 9606  
603 4HKZ 2 B Trastuzumab heavy chain 9606  
604 3GKZ 1 A anti-methamphetamine single chain Fv 10090  
605 1R3J 1 A Antibody Fab fragment light chain 10090  
606 1R3J 2 B Antibody Fab fragment heavy chain 10090  
607 1MFB 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
608 1MFB 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
609 1RIU 1 L Fab M82G2, Light Chain 10090  
610 1RIU 2 H Fab M82G2, Heavy Chain 10090  
611 3OKK 1 A S25-39 Fab (IgG1k) light chain 10090  
612 3OKK 2 B S25-39 Fab (IgG1k) heavy chain 10090  
613 1MFE 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
614 1MFE 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
615 4M6M 1 L CNTO1959 light chain 9606  
616 4M6M 2 H CNTO1959 heavy chain FD 9606  
617 3BPC 1 A Fab, antibody fragment (IgG1k), light chain 10090  
618 3BPC 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
619 4OCS 1 L CAP256-VRC26.10 light chain Fab 9606  
620 4OCS 2 H CAP256-VRC26.10 heavy chain Fab 9606  
621 3SO3 2 B A11 FAB light chain 9606  
622 3SO3 3 C A11 FAB heavy chain 9606  
623 2YK1 1 H FAB FRAGMENT, HEAVY CHAIN 9606  
624 2YK1 2 L FAB FRAGMENT, LIGHT CHAIN 9606  
625 3IDG 1 A 2F5 Fab light chain 9606  
626 3IDG 2 B 2F5 Fab heavy chain 9606  
627 2AJX 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
628 2AJX 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
629 3RU8 2 H Antibody b12, Heavy Chain 9606  
630 3RU8 3 L Antibody b12, Light Chain 9606  
631 1KN2 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
632 1KN2 2 H IG ANTIBODY D2.3 (HEAVY CHAIN) 10090  
633 1KN4 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
634 1KN4 2 H IG ANTIBODY D2.3 (HEAVY CHAIN) 10090  
635 1MFC 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
636 1MFC 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
637 1NQB 1 A, C SINGLE-CHAIN ANTIBODY FRAGMENT VH DOMAIN RESIDUES 2 - 120, VL DOMAIN RESIDUES 121 - 233 10090  
638 2MCG 1 1, 2 IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) 9606  
639 3OAU 1 H Fab 2G12, heavy chain Fab 9606  
640 3OAU 2 L Fab 2G12, light chain 9606  
641 2BRR 1 H, Y MN20B9.34 ANTI-P1.4 ANTIBODY, FAB HEAVY CHAIN 10090  
642 2BRR 2 L, X MN20B9.34 ANTI-P1.4 ANTIBODY, FAB LIGHT CHAIN 10090  
643 1LGV 1 A, B IMMUNOGLOBULIN LAMBDA LIGHT CHAIN 9606  
644 3TNN 1 A, C, E, H Fab heavy chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5 9606  
645 3TNN 2 B, D, F, L Fab light chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5 9606  
646 3TJE 1 L Fab E09, light chain 9606  
647 3TJE 2 H Fab E09, heavy chain 9606  
648 3HZV 1 A S73-2 Fab (IgG1k) light chain 10090  
649 3HZV 2 B S73-2 Fab (IgG1k) heavy chain 10090  
650 4WY7 1 H Fab 4E10 Heavy chain 9606  
651 4WY7 2 L Fab 4E10Light chain 9606  
652 1NBZ 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
653 1NBZ 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090  
654 3LS5 1 L Light chain of antibody Fab fragment 10090  
655 3LS5 2 H Heavy chain of antibody Fab fragment 10090  
656 3FO9 1 A, L Immunoglobulin IGG2A - light chain light chain of 33F12 Fab' fragment 10090  
657 3FO9 2 B, H Immunoglobulin IGG2A - heavy chain heavy chain of 33F12 Fab' fragment 10090  
658 4FZE 1 L N26_i1 Fab light chain 9606  
659 4FZE 2 H N26_i1 Fab heavy chain 9606  
660 1E4W 1 H TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
661 1E4W 2 L TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
662 3U0W 1 H Fab Heavy Chain, Ig gamma-1 chain C region chimera of Fab Heavy Chain from mouse, Ig gamma-1 chain C region from human 10090  
663 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090  
664 4JO1 1 L, M monoclonal anti-HIV-1 gp120 V3 antibody R56 light chain Fab 9986  
665 4JO1 2 H, I monoclonal anti-HIV-1 gp120 V3 antibody R56 heavy chain Fab 9986  
666 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
667 2O5X 2 H chimeric antibody Fab 1E9-DB3 heavy chain 10090  
668 4HIE 1 A Fab 023.102 9606  
669 4HIE 2 B Antibody 023.102 9606  
670 1FL3 1 A, H BLUE FLUORESCENT ANTIBODY (19G2)-HEAVY CHAIN FAB FRAGMENT 10090  
671 1FL3 2 B, L BLUE FLUORESCENT ANTIBODY (19G2)-LIGHT CHAIN FAB FRAGMENT 10090  
672 4LEX 1 L FAB HEAVY CHAIN 10090  
673 4LEX 2 H FAB LIGHT CHAIN 10090  
674 3QEG 1 H Fab fragment of human anti-HIV antibody N12-i2, heavy chain Fab heavy chain 9606  
675 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606  
676 3SE9 2 H Heavy chain of antibody VRC-PG04 Antigen binding fragement of heavy chain 9606  
677 3SE9 3 L Light chain of antibody VRC-PG04 antibody light chain 9606  
678 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606  
679 1CE1 2 H PROTEIN (CAMPATH-1H:HEAVY CHAIN) FAB 9606  
680 1Q0Y 1 L Fab 9B1, Light chain 10090  
681 1Q0Y 2 H Fab 9B1, Heavy chain 10090  
682 3EYS 1 L If kappa light chain 10090  
683 3EYS 2 H PFA1 Fab Heavy Chain 10090  
684 3WE6 1 A mAb Fab H fragment 10090  
685 3WE6 2 B mAb Fab L fragment 10090  
686 12E8 1 L, M IGG1-KAPPA 2E8 FAB (LIGHT CHAIN) FAB FRAGMENT 10090  
687 12E8 2 H, P IGG1-KAPPA 2E8 FAB (HEAVY CHAIN) FAB FRAGMENT 10090  
688 1A3R 1 L IGG2A 8F5 FAB (LIGHT CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
689 1A3R 2 H IGG2A 8F5 FAB (HEAVY CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
690 3ZL4 1 H A17 ANTIBODY FAB FRAGMENT HEAVY CHAIN 9606  
691 1HIL 1 A, C IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090  
692 1HIL 2 B, D IGG2A-KAPPA 17/9 FAB (HEAVY CHAIN) 10090  
693 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
694 2NY2 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
695 1F58 1 L PROTEIN (IGG1 ANTIBODY 58.2 (LIGHT CHAIN)) 10090  
696 1F58 2 H PROTEIN (IGG1 ANTIBODY 58.2 (HEAVY CHAIN)) 10090  
697 1QKZ 2 H ANTIBODY FAB 10090  
698 1QKZ 3 L ANTIBODY FAB 10090  
699 2G60 1 L anti-FLAG M2 Fab light chain 10090  
700 2G60 2 H anti-FLAG M2 Fab heavy chain 10090  
701 4GQP 1 H Anti-METH scFv 10090  
702 4KMT 1 L light chain O12/KAPPA Fab 9606  
703 4KMT 2 H heavy chain 5-51/CNTO888/IGG1 Fab 9606  
704 2FR4 2 A, L antibody light chain FAB antigen-binding fragment 10090  
705 2FR4 3 B, H antibody heavy chain FAB antigen-binding fragment 10090  
706 4H0H 1 B 2D10 scFv 10090  
707 3NZH 1 L 5F6 LIGHT CHAIN 10090  
708 3NZH 2 H 5F6 HEAVY CHAIN 10090  
709 1RHH 1 A, C Fab X5, light chain 9606  
710 1RHH 2 B, D Fab X5, heavy chain 9606  
711 2Q76 1 A, C Fab F10.6.6 fragment Light Chain domain VL and CL 10090  
712 2Q76 2 B, D Fab F10.6.6 fragment Heavy Chain domain VH and CH1 10090  
713 1TJG 1 L FAB 2F5 Light Chain 9606  
714 1TJG 2 H FAB 2F5 Heavy Chain 9606  
715 1YEF 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
716 1YEF 2 H IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
717 1YEG 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
718 1YEG 2 H IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
719 4LLW 2 B, D light chain Clambda 9606  
720 3IFO 1 A, H 10D5 FAB antibody heavy chain 10090  
721 3IFO 2 B, L 10D5 FAB antibody light chain 10090  
722 1SM3 1 L SM3 ANTIBODY FAB FRAGMENT 10090  
723 1SM3 2 H SM3 ANTIBODY FAB FRAGMENT 10090  
724 4OT1 2 H SM5-1 Fab Heavy Chain 9606  
725 4OT1 3 L SM5-1 Fab Light Chain 9606  
726 4JPI 1 A, H Putative VRC01 germline Fab heavy chain 9606  
727 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606  
728 4M7J 1 H S25-26 Fab (IgG1k) heavy chain 10090  
729 4M7J 2 L S25-26 Fab (Igg1k) light chain 10090  
730 4XTR 2 C, E Antibody Heavy chain 32630  
731 4XTR 3 D, F Antibody Light chain 32630  
732 1UYW 1 H, M FAB ANTIBODY HEAVY CHAIN 10090  
733 1UYW 2 L, N FAB ANTIBODY LIGHT CHAIN 10090  
734 2XQY 2 G, J A13-D6.3 MONOCLONAL ANTIBODY HEAVY CHAIN OF FAB FRAGMENT 10090  
735 2XQY 3 K, L A13-D6.3 MONOCLONAL ANTIBODY LIGHT CHAIN OF FAB FRAGMENT 10090  
736 3O6K 1 L 11H6H1 Fab' light chain 10090  
737 3O6K 2 H 11H6H1 Fab' heavy chain 10090  
738 3C5S 1 A, C Fab F22-4 light chain 10090  
739 3C5S 2 B, D Fab F22-4 heavy chain 10090  
740 1RZ7 1 L Fab 48d light chain 9606  
741 1RZ7 2 H Fab 48d heavy chain 9606  
742 1RZG 1 A, C Fab 412d light chain 9606  
743 1RZG 2 B, D Fab 412d heavy chain 9606  
744 1GPO 1 L, M ANTIBODY M41 FAB FRAGMENT 10090  
745 1GPO 2 H, I ANTIBODY M41 FAB FRAGMENT 10090  
746 3QOS 1 A, L B3 (IGKV4-1) light chain 9606  
747 3QOS 2 B, H 3-23 (IGHV3-23) heavy chain FD 9606  
748 2HVK 1 A Antibody Fab heavy chain 10090  
749 2HVK 2 B Antibody Fab light chain 10090  
750 1MJJ 1 A, L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
751 1MJJ 2 B, H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090  
752 3PGF 2 H SAB Heavy Chain 9606  
753 3PGF 3 L SAB Light Chain 9606  
754 2QHR 1 H 13F6-1-2 Fab fragment heavy chain 10090  
755 2QHR 2 L 13F6-1-2 Fab fragment V lambda x light chain 10090  
756 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606  
757 1IQD 2 B HUMAN MONOCLONAL BO2C11 FAB HEAVY CHAIN 9606  
758 1BJM 1 A, B LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER CRYSTALLIZED IN NA/K SO4 9606  
759 1P2C 1 A, D light chain anti-lysozyme antibody F10.6.6 10090  
760 1P2C 2 B, E heavy chain VH+CH1 anti-lysozyme antibody F10.6.6 10090  
761 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
762 2NY4 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
763 4NJ9 1 L 8B10 light chain 10090  
764 4NJ9 2 H 8B10 heavy chain 10090  
765 1ORS 1 A 33H1 Fab light chain 10090  
766 1ORS 2 B 33H1 Fab heavy chain 10090  
767 4G6F 1 B, H 10E8 Heavy Chain Fragment of Antigen Binding 9606  
768 4G6F 2 D, L 10E8 Light Chain Fragment of Antigen Binding 9606  
769 1MLB 1 A IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090  
770 1MLB 2 B IGG1-KAPPA D44.1 FAB (HEAVY CHAIN) 10090  
771 2ZKH 1 L Monoclonal TN1 FAB light chain 9606  
772 2ZKH 2 H Monoclonal TN1 FAB heavy chain 9606  
773 3OJD 1 A Fab V2D2 Light chain 10090  
774 3OJD 2 B Fab V2D2 Heavy chain 10090  
775 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
776 2NY3 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
777 1DCL 1 A, B MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER 9606  
778 3ZKN 2 C, H FAB HEAVY CHAIN 10090  
779 3ZKN 3 D, L FAB LIGHT CHAIN 10090  
780 1LO0 1 L, X If kappa light chain Fab fragment 10090  
781 1LO0 2 H, Y Ig gamma 2a heavy chain 10090  
782 35C8 1 L IGG 5C8 FAB 10090  
783 35C8 2 H IGG 5C8 FAB 10090  
784 1MIE 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090  
785 1MIE 2 H IMMUNOGLOBULIN MS5-393 Fab fragment, HEAVY CHAIN 10090  
786 4DVB 1 A, H Fab fragment of pro-uPA antibody mAb-112 10090  
787 4DVB 2 B, L Fab fragment of pro-uPA antibody mAb-112 10090  
788 2B1H 1 L Fab 2219, light chain light chain 9606  
789 2B1H 2 H Fab 2219, heavy chain heavy chain 9606  
790 3MA9 2 H Fab8066 FAB ANTIBODY FRAGMENT, Heavy Chain 9606  
791 3MA9 3 L Fab8066 FAB ANTIBODY FRAGMENT, Light Chain 9606  
792 1RFD 1 L Fab M82G2, Light Chain 10090  
793 1RFD 2 H Fab M82G2, Heavy Chain 10090  
794 1MFD 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
795 1MFD 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
796 2QQN 2 H Antibody heavy chain 9606  
797 2QQN 3 L Antibody light chain 9606  
798 3RVT 1 C Fab fragment of 4C1 antibody - light chain 10090  
799 3RVT 2 D Fab fragment of 4C1 antibody - heavy chain 10090  
800 1JVK 1 A, B IMMUNOGLOBULIN LAMBDA LIGHT CHAIN 9606  
801 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
802 3L5W 2 B, H C836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
803 3MCG 1 1, 2 IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) 9606  
804 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
805 2NY1 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
806 4OGY 2 H, M DX-2930 HEAVY CHAIN 9606  
807 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606  
808 3THM 1 L Fab EP6b_B01, light chain 9606  
809 3THM 2 H Fab EP6b_B01, heavy chain 9606  
810 3EOT 1 H FAB FRAGMENT, HEAVY CHAIN 10090  
811 3EOT 2 L FAB FRAGMENT, LIGHT CHAIN 10090  
812 4MA7 2 H POM1 heavy chain Fab 10090  
813 4MA7 3 L POM1 light chain Fab 10090  
814 1LO2 1 L, X If kappa light chain Fab fragment 10090  
815 1LO2 2 H, Y Ig gamma 2a heavy chain 10090  
816 1UZ6 1 E, L, M, V IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
817 1UZ6 2 F, H, P, W IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090  
818 2D03 1 L anti-glycophorin A type N immunoglobulin light chain 10090  
819 2D03 2 H anti-glycophorin A type N immunoglobulin heavy chain 10090  
820 3UJT 1 H, I Ab-52 heavy chain Fab fragment 10090  
821 3UJT 2 L, M Ab-52 light chain Fab fragment 10090  
822 3O6L 1 L 11H6H1 Fab' light chain 10090  
823 3O6L 2 H 11H6H1 Fab' heavy chain 10090  
824 3E8U 1 H Fab 106.3 heavy chain 10090  
825 3E8U 2 L Fab 106.3 light chain 10090  
826 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
827 1C5B 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090  
828 4JZN 1 A, C, I Anti-HCV E2 Fab HC84-1 heavy chain 9606  
829 4JZN 2 B, D, P Anti-HCV E2 Fab HC84-1 light chain 9606  
830 2CMR 2 H D5 9606  
831 2CMR 3 L D5 9606  
832 3GNM 1 L JAA-F11 Fab Antibody Fragment, Light Chain 10090  
833 3GNM 2 H JAA-F11 Fab Antibody Fragment, Heavy Chain 10090  
834 2FD6 2 L L chain of Fab of ATN-615 anti-uPAR antibody 10090  
835 2FD6 3 H H chain of Fab of ATN-615 anti-uPAR antibody 10090  
836 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606  
837 4R4B 2 B, D, F, H FAB 2.2C HEAVY CHAIN 9606  
838 1TET 1 L IGG1 TE33 FAB (LIGHT CHAIN) 10090  
839 1TET 2 H IGG1 TE33 FAB (HEAVY CHAIN) 10090  
840 4BZ2 2 H FAB 2D73 HEAVY CHAIN 10090  
841 4BZ2 3 L FAB 2D73 LIGHT CHAIN 10090  
842 2AEP 2 H FAB heavy chain 10090  
843 2AEP 3 L FAB light chain 10090  
844 4MSW 1 A ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
845 4MSW 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
846 4FQH 1 A, H antibody CR9114 heavy chain Fab 9606  
847 4FQH 2 B, L antibody CR9114 light chain Fab Lambda 9606  
848 3GRW 2 L Fab light chain 9606  
849 3GRW 3 H Fab heavy chain 9606  
850 4KTD 1 H GE136 Heavy Chain Fab Fab fragment 9544  
851 4KTD 2 L GE136 Light Chain Fab 9544  
852 3LS4 1 L Light chain of antibody Fab fragment 10090  
853 3LS4 2 H Heavy chain of antibody Fab fragment 10090  
854 1D5I 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
855 1D5I 2 H CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (HEAVY CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
856 4Q2Z 1 A, H Heavy chain of Fab fragment of HIV vaccine-elicited CD4bs-directed antibody 9544  
857 4Q2Z 2 B, L Light chain of Fab fragment of HIV vaccine-elicited CD4bs-directed antibody 9544  
858 1OSP 1 L FAB 184.1 10090  
859 1OSP 2 H FAB 184.1 10090  
860 1F8T 1 L ANTIBODY FAB FRAGMENT (LIGHT CHAIN) 10090  
861 1F8T 2 H ANTIBODY FAB FRAGMENT (HEAVY CHAIN) 10090  
862 4LSP 2 H HEAVY CHAIN OF ANTIBODY VRC-CH31 9606  
863 4LSP 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 9606  
864 2R2H 1 A Fab, antibody fragment (IgG1k), light chain 10090  
865 2R2H 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
866 1DQJ 1 A ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
867 1DQJ 2 B ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090  
868 1RIV 1 L Fab M82G2, Light Chain 10090  
869 1RIV 2 H Fab M82G2, Heavy Chain 10090  
870 3QCU 1 H, I LT3015 antibody Fab fragment, heavy chain 9606  
871 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606  
872 1Q9K 1 A S25-2 Fab (IgG1k) light chain Light Chain kappa 10090  
873 1Q9K 2 B S25-2 Fab (IgG1k) heavy chain Heavy Chain g1 10090  
874 4OTX 1 L, M N203 light chain Fab 10090  
875 4OTX 2 H, I N203 heavy chain Fab 10090  
876 4EOW 1 H MB007 human IgG1 Fab fragment heavy chain 9606  
877 4EOW 2 L MB007 IgG1 Fab fragment light chain 9606  
878 1K4C 1 A antibody Fab fragment heavy chain 10090  
879 1K4C 2 B antibody Fab fragment light chain 10090  
880 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
881 2NXZ 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
882 1E4X 1 H TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
883 1E4X 2 I TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
884 1E4X 3 L, M TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
885 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606  
886 1UJ3 2 B IgG Fab heavy chain anti-tissue-factor antibody hATR-5 Fab 9606  
887 3CLF 1 L Fab light chain 10090  
888 3CLF 2 H Fab heavy chain 10090  
889 4HIX 1 H Humanized 3D6 Fab heavy chain 10090  
890 4HIX 2 L Humanized 3D6 Fab light chain 10090  
891 4LKC 1 A Fab fragment of PCSK9 antibody 9606  
892 4LKC 2 B Fab fragment of PCSK9 antibody 9606  
893 1MHH 1 A, C Fab, light chain 10090  
894 1MHH 2 B, D Fab, heavy chain 10090  
895 4GW5 1 A, C Fab Light Chain 10090  
896 4GW5 2 B, D Fab Heavy Chain 10090  
897 1W72 4 H, I HYB3 HEAVY CHAIN FAB FRAGMENT, RESIDUES 1-211 9606  
898 1W72 5 L, M HYB3 LIGHT CHAIN FAB FRAGMENT, RESIDUES 1-228 9606  
899 4OM1 2 H Antigen binding fragment of heavy chain: Antibody VRC01 9606  
900 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
901 4KZD 1 H BL3-6 Fab antibody, heavy chain 10090  
902 4KZD 2 L BL3-6 Fab antibody, light chain 10090  
903 4HCR 1 H, M PF-547659 heavy chain 9606  
904 4HCR 2 L, N PF-547659 light chain 9606  
905 4CNI 1 A, H OLOKIZUMAB HEAVY CHAIN, FAB PORTION FAB PORTION 9606  
906 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606  
907 1C1E 1 L CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN) FAB FRAGMENT 10090  
908 1C1E 2 H CATALYTIC ANTIBODY 1E9 (HEAVY CHAIN) FAB FRAGMENT 10090  
909 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
910 1TJH 2 H anti-HIV-1 antibody 2F5 Heavy Chain 9606  
911 1YEK 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
912 1YEK 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
913 4HIH 1 A, C Fab 023.102 9606  
914 4HIH 2 B, D Antibody 023.102 9606  
915 3FFD 1 A Monoclonal antibody, heavy chain, Fab fragment 10090  
916 3FFD 2 B Monoclonal antibody, light chain, Fab fragment 10090  
917 1D6V 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
918 1D6V 2 H CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (HEAVY CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
919 1YY8 1 A, C Cetuximab Fab Light chain 10090  
920 1YY8 2 B, D Cetuximab Fab Heavy chain 10090  
921 1DZB 1 A, B SCFV FRAGMENT 1F9 SEE REMARK 400 10090  
922 4ONG 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090  
923 4ONG 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
924 4ETQ 1 A, H anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, heavy chain Fab 10090  
925 4ETQ 2 B, L anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, light chain Fab 10090  
926 3QPX 1 L Fab C2507 light chain 10116  
927 3QPX 2 H Fab C2507 heavy chain 10116  
928 3U4E 2 A, H PG9 Heavy Chain 9606  
929 3U4E 3 B, L PG9 Light Chain 9606  
930 2R0Z 1 L IgG2a Fab fragment light chain light chain 10090  
931 2R0Z 2 H IgG2a Fab fragment heavy chain, Fd portion Fd portion of heavy chain 10090  
932 3DRQ 1 A 2F5 Fab' light chain 9606  
933 3DRQ 2 B 2F5 Fab' heavy chain 9606  
934 3NIG 3 E, H Monoclonal antibody 10E5 heavy chain 10090  
935 3NIG 4 F, L Monoclonal antibody 10E5 light chain 10090  
936 3UZE 1 A, B Variable domains of murine anti-dengue Mab 4E11 Single chain variable fragment 10090  
937 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
938 1TJI 2 H anti-HIV-1 antibody 2F5 Heavy Chain 9606  
939 1KEM 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
940 1KEM 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
941 25C8 1 L IGG 5C8 FAB 10090  
942 25C8 2 H IGG 5C8 FAB 10090  
943 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606  
944 3QNX 2 B Fab fragment of IMMUNOGLOBULIN A1 HEAVY CHAIN 9606  
945 3PHQ 1 A S64-4 Fab (IgG1) light chain 10090  
946 3PHQ 2 B S64-4 Fab (IgG1) heavy chain 10090  
947 3G5V 1 A 806 light chain 10090  
948 3G5V 2 B 808 heavy chain 10090  
949 4OLZ 2 H Antigen binding fragment of heavy chain: Antibody VRC01 9606  
950 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
951 4GSD 1 L H5.3 Fab Light Chain 9606  
952 4GSD 2 H H5.3 Fab Heavy Chain 9606  
953 3UZV 2 B anti-dengue Mab 4E11 Single chain variable fragment 10090  
954 3D0V 1 A 2F5 Fab heavy chain 9606  
955 3D0V 2 B 2F5 Fab light chain 9606  
956 2C1P 1 A, L IGK-C PROTEIN 10090  
957 2C1P 2 B, H IGH-4 PROTEIN FAB-FRAGMENT 10090  
958 3BJL 1 A, B LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER CRYSTALLIZED IN AMMONIUM SULFATE 9606  
959 4O51 1 A, C, E, L QAA-2095-2 light chain 9986  
960 4O51 2 B, D, F, H QAA-2095-2 heavy chain 9986  
961 3S34 1 L 1121B Fab light chain 10090  
962 3S34 2 H 1121B Fab heavy chain 10090  
963 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
964 1GAF 2 H CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
965 2P7T 1 A FAB-A 10090  
966 2P7T 2 B FAB-B 10090  
967 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
968 3MOD 3 H ANTI-HIV-1 ANTIBODY 2F5 HEAVY CHAIN 9606  
969 4HXA 1 L 13D9 FAB LIGHT CHAIN 10090  
970 4HXA 2 H 13D9 FAB HEAVY CHAIN 10090  
971 1NDM 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-26 light chain 10090  
972 1NDM 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-26 10090  
973 2IQA 1 A, L IgG2a Fab fragment PFA2 Kappa light chain 10090  
974 2IQA 2 B, H IgG2a Fab fragment PFA2 heavy chain 10090  
975 1H0D 1 A ANTIBODY FAB FRAGMENT, LIGHT CHAIN HINGE REGION OBSERVED IN THE FAB FRAGMENT 9606  
976 1H0D 2 B ANTIBODY FAB FRAGMENT, HEAVY CHAIN HINGE REGION OBSERVED IN THE FAB FRAGMENT 9606  
977 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
978 2F5B 2 H PROTEIN (ANTIBODY 2F5 (HEAVY CHAIN)) FAB' 9606  
979 3MNW 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and human Fc 10090  
980 3MNW 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and human Fc 10090  
981 1IL1 1 A monoclonal antibody G3-519 (heavy chain) FAB FRAGMENT 10090  
982 1IL1 2 B monoclonal antibody G3-519 (light chain) FAB FRAGMENT 10090  
983 1NC2 1 A, C MONOCLONAL ANTIBODY 2D12.5, LAMBDA LIGHT CHAIN Fab 10090  
984 1NC2 2 B MONOCLONAL ANTIBODY 2D12.5, IGG1 GAMMA HEAVY CHAIN Fab 10090  
985 1NC2 3 D MONOCLONAL ANTIBODY 2D12.5, IGG1 GAMMA HEAVY CHAIN Fab 10090  
986 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
987 1U8I 2 B ANTIBODY 2F5 (HEAVY CHAIN) 9606  
988 2VDR 4 H MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN 10090  
989 2VDR 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
990 1IND 1 L IGG1-LAMBDA CHA255 FAB (LIGHT CHAIN) 10090  
991 1IND 2 H IGG1-LAMBDA CHA255 FAB (HEAVY CHAIN) 10090  
992 2RCS 1 L IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090  
993 2RCS 2 H IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
994 1JGL 1 L Ig kappa-chain 10090  
995 1JGL 2 H Ig gamma-1-chain residues 1-215 10090  
996 4G6J 2 H heavy chain of antibody binding fragment of canakinumab heavy chain of antibody binding fragment of canakinumab 9606  
997 4G6J 3 L light chain of antibody binding fragment of canakinumab light chain of antibody binding fragment of canakinumab 9606  
998 2AJ3 1 A, C, E Fab m18, Light Chain 9606  
999 2AJ3 2 B, D, F Fab m18, Heavy Chain 9606  
1000 1SY6 1 L OKT3 Fab light chain fab fragment light chain 10090  
 
Sequence Clusters for the Sequence Entities in PDB 1TJH
Entity #1: Chains: L - anti-HIV-1 antibody 2F5 Light Chain protein, length: 214 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 7 8001
95% 3 41 989
90% 102 389 4
70% 371 1350 3
50% 909 3218 1
40% 910 3219 1
30% 999 3801 1
Entity #2: Chains: H - anti-HIV-1 antibody 2F5 Heavy Chain protein, length: 237 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 4 15944
95% 3 41 988
90% 3 41 1007
70% 442 1552 2
50% 910 3218 1
40% 911 3219 1
30% 1000 3801 1
Entity #3: Chains: P - Envelope glycoprotein GP41 protein, length: 13 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
 

Documentation

Click here for more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB.